TSX closed
Loading markets…

Advertisement

PARTNER SPOTLIGHT

CIBC Investor's Edge

Get 200 free trades when you open an eligible CIBC Investor's Edge account.

  • 200 free stock & ETF trades
  • Unlimited commission-free trades on 180+ select ETFs
  • Offer ends September 30, 2026
Stocks/TSX-V/LSL

LSL Pharma Group Inc. (LSL : TSX-V)

Common Stock

$0.33

CAD

-0.01 (-1.52%)

Last updated: 2026-09-22

Follow LSL

LSL

LSL Pharma Group Inc.

Source:WealthAwesomeWealthAwesome
$0.03 (-8.45%)
30 day period
$0.30$0.34$0.38Aug 7Aug 31Sep 22

Performance

1 Day

-1.52%

1 Week

+6.56%

1 Month

-7.14%

YTD

-7.14%

Key Statistics

Market Cap

$41.19M

52W High

$0.56

52W Low

$0.30

P/E Ratio

-

50 Day MA

$0.34

200 Day MA

$0.38

Beta

-0.52

Dividend Yield

-

Advertisement

Technical Indicators

Price vs 50-Day SMA

Below 50 SMA

Price vs 200-Day SMA

Below 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
9/22/2026$0.33$0.33$0.33$0.33$0.3310,500
9/21/2026$0.32$0.33$0.32$0.33$0.3391,000
9/18/2026$0.32$0.32$0.32$0.32$0.322,500
9/17/2026$0.33$0.33$0.32$0.32$0.325,000
9/16/2026$0.31$0.33$0.30$0.32$0.3282,500
9/15/2026$0.32$0.32$0.30$0.30$0.307,600
9/14/2026$0.32$0.32$0.30$0.31$0.3127,500
9/11/2026$0.33$0.33$0.32$0.32$0.324,000
9/10/2026$0.33$0.33$0.32$0.32$0.3211,525
9/9/2026$0.34$0.34$0.33$0.33$0.333,500

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on LSL's historical volatility

HistoricalForecast68%95%
C$0.20C$0.27C$0.34C$0.41C$0.48C$0.56TodayMay 12Jul 16Sep 22Nov 4Dec 18Jan 30

30-Day Vol

40.6%

Annualized

90-Day Vol

47.2%

Annualized

Trend (90d)

+6.5%

Annualized drift

90d Mean

C$0.33

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.33C$0.28C$0.38
60 trading daysC$0.33C$0.27C$0.40
90 trading daysC$0.33C$0.26C$0.42

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About LSL Pharma Group Inc.

LSL Pharma Group Inc. develops, manufactures, and commercializes sterile pharmaceutical products, cosmetic products, and natural health products in Canada, the United States, and internationally. It offers dietary supplements and vitamins in the tablet and capsule form; niche sterile ophthalmic products in the form of ointments and drops; and cosmetic, pharmaceutical, as well as natural health products in sachets, capsules, loose powder, blister packs, and liquids for pharmacy banners and hospitals. The company is headquartered in Boucherville, Canada.

Financials

Revenue (TTM)
$41.83M
EBITDA
$-1.61M
Profit Margin
-17.54%
ROE (TTM)
-31.63%
EPS (Diluted)
-0.06
Book Value
0.17

Classification

Sector
Health Care
Industry
Pharmaceuticals
Group
Pharmaceuticals, Biotechnology & Life Sciences

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Advertisement

Common Questions About LSL

Market movers

Recent TSX-V movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
ESXREssex Resources Corp.$0.40+182.14%
RCR-PCanna 8 Investment Trust$0.01+100.00%
BARKBlack Spruce Exploration Inc.$0.04+50.00%
AUGCAu Gold Corp$0.27+38.46%
TIEColoured Ties Capital Inc$1.16+36.47%
GWMGalway Metals Inc.$0.89+34.85%
FRNTFRNT Financial Inc$0.04+33.33%
SNVSonoro Energy Ltd$0.02+33.33%

LSL.V news timeline

4 articles covering LSL.V, most recent first

Latest

What's Going On With LSL Pharma Group Inc. Stock Tuesday?

Stocks

Advertisement